mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD
Source: Bioprocess Online
Nevan Charles Elam, JD founded Rezolute Bio ten years ago on the heels of a complex career intersecting law, high tech, and life sciences. On this episode of the Business of Biotech, Elam shares the company's rationale for pursuing congenital hyperinsulinism and diabetic macular edema therapeutics by leveraging monoclonal antibodies and discusses the company's approach to process development and manufacturing.
This website uses cookies to ensure you get the best experience on our website. Learn more